Nadège Loaëc

6.3k citations

37 papers · 1.1k indexed · h-index 21

Molecular Biology
Organic Chemistry top 5%
Oncology
Public Health, Environmental and Occupational Health top 10%
Genetics

Co-authors: Laurent Meijer Thierry Besson Olivier Lozach Pascal Marchand Marie‐Renée Nourrisson Conrad Kunick Lutz Preu Hervé Galons
Topics: Quinazolinone synthesis and applications (8 papers)Synthesis and Characterization of Heterocyclic Compounds (6 papers)Synthesis and biological activity (6 papers)
Cited by: Organic Chemistry Toxicology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research PLoS ONE
Partner nations: France Germany United Kingdom

In The Last Decade

Nadège Loaëc

36 papers receiving 1.1k citations

Peers

Countries citing papers authored by Nadège Loaëc

Since Specialization

Citations

This map shows the geographic impact of Nadège Loaëc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Loaëc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Loaëc more than expected).

Fields of papers citing papers by Nadège Loaëc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadège Loaëc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Loaëc. The network helps show where Nadège Loaëc may publish in the future.

Co-authorship network of co-authors of Nadège Loaëc

This figure shows the co-authorship network connecting the top 25 collaborators of Nadège Loaëc. A scholar is included among the top collaborators of Nadège Loaëc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadège Loaëc. Nadège Loaëc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Epstein-Barr virus EBNA1 protein binds to G-quadruplexes in its own mRNA hence controlling its expression and immune evasion of the virus 2025 ·Nucleic Acids Research ·(unknown),Nadège Loaëc,(unknown),(unknown),(unknown),(unknown),Marie‐Paule Teulade‐Fichou,Laurent Corcos,Rodrigo Prado Martins,Anton Granzhan,Marc Blondel	0
2	The hide-and-seek game of the oncogenic Epstein-Barr virus-encoded EBNA1 protein with the immune system: An RNA G-quadruplex tale 2023 ·Biochimie ·(unknown),Nadège Loaëc,(unknown),(unknown),(unknown),Rodrigo Prado Martins,Anton Granzhan,Marc Blondel	11
3	Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA 2023 ·Nucleic Acids Research ·(unknown),(unknown),(unknown),Nadège Loaëc,(unknown),(unknown),(unknown),Laurent Corcos,Marie‐Paule Teulade‐Fichou,Anton Granzhan,Marc Blondel	11
4	Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a 2019 ·Human Molecular Genetics ·Damien Maréchal,Véronique Brault,(unknown),(unknown),Patricia Lopes Pereira,Nadège Loaëc,Marie‐Christine Birling,Gaëlle Friocourt,Marc Blondel,Yann Hérault	41
5	Novel cationic bis(acylhydrazones) as modulators of Epstein–Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA 2019 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Rodrigo Prado Martins,Nadège Loaëc,Hang Won Kang,María José Lista,Claire Beauvineau,Jorge González‐García,Régis Guillot,Cécile Voisset,Chrysoula Daskalogianni,Robin Fåhræus,Marie‐Paule Teulade‐Fichou,Marc Blondel,Anton Granzhan	45
6	Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype 2018 ·PLoS ONE ·Anne Walter,A. Chaikuad,Renate Helmer,Nadège Loaëc,Lutz Preu,Ingo Ott,Stefan Knapp,Laurent Meijer,Conrad Kunick	21
7	Synthesis and preliminary in vitro kinase inhibition evaluation of new diversely substituted pyrido[3,4-g]quinazoline derivatives 2016 ·Bioorganic & Medicinal Chemistry Letters ·Waël Zeinyeh,(unknown),Lionel Nauton,Nadège Loaëc,Laurent Meijer,Vincent Théry,Fabrice Anizon,F Giraud,Pascale Moreau	17
8	Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor 2016 ·European Journal of Medicinal Chemistry ·(unknown),Nadège Loaëc,Benoît Villiers,Eric Prina,Gérald F. Späth,Hervé Galons,Laurent Meijer,Nassima Oumata	31
9	5-Substituted 3-chlorokenpaullone derivatives are potent inhibitors of Trypanosoma brucei bloodstream forms 2016 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Diego Benítez,Andrea Medeiros,Lutz Preu,Nadège Loaëc,Laurent Meijer,Oliver Koch,Marcelo A. Comini,Conrad Kunick	19
10	Synthesis of Thiazolo[5,4-f]quinazolin-9(8H)-ones as Multi-Target Directed Ligands of Ser/Thr Kinases 2016 ·Molecules ·Damien Hédou,(unknown),Nadège Loaëc,Laurent Meijer,Corinne Fruit,Thierry Besson	13
11	Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure 2016 ·European Journal of Medicinal Chemistry ·(unknown),Waël Zeinyeh,(unknown),Lionel Nauton,Vincent Théry,Stefan Knapp,A. Chaikuad,Nadège Loaëc,Laurent Meijer,Fabrice Anizon,F Giraud,Pascale Moreau	35
12	10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A 2015 ·Journal of Medicinal Chemistry ·(unknown),A. Chaikuad,Anja Becker,Nadège Loaëc,Olivier Lozach,(unknown),Walter Becker,Peter G. Jones,Lutz Preu,Knut Baumann,Stefan Knapp,Laurent Meijer,Conrad Kunick	89
13	Synthesis and molecular modelling studies of 8-arylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors 2014 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Pascal Marchand,Marie‐Renée Nourrisson,Cédric Logé,Gaël Coadou,Nadège Loaëc,Laurent Meijer,Thierry Besson	47
14	Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis 2014 ·Neuro-Oncology ·(unknown),(unknown),(unknown),Laurence Desrues,Marie‐Thérèse Schouft,Vadim Le Joncour,(unknown),Gildas Lyvinec,Benoı̂t Joseph,Nadège Loaëc,Laurent Meijer,Jérôme Honnorat,Pierrick Gandolfo,Hélène Castel	24
15	9- and 11-substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma 2014 ·European Journal of Medicinal Chemistry ·(unknown),Diego Benítez,(unknown),(unknown),Hanna Erdmann,Lutz Preu,Oliver Koch,Christoph Hölscher,Nadège Loaëc,Laurent Meijer,Marcelo A. Comini,Conrad Kunick	35
16	CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells 2013 ·Oncogene ·(unknown),Klaus Godl,Nadège Loaëc,Céline Bruyère,Nathalie Desban,Nassima Oumata,Hervé Galons,Theodoros I. Roumeliotis,Ευγενία Γιαννοπούλου,José Grenet,(unknown),Jill M. Lahti,Nicolas Mouchet,(unknown),Spiros D. Garbis,Laurent Meijer	54
17	Synthesis, Resolution, and Biological Evaluation of Atropisomeric (aR)- and (aS)-16-Methyllamellarins N: Unique Effects of the Axial Chirality on the Selectivity of Protein Kinases Inhibition 2013 ·Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),Junji Tanaka,Nadège Loaëc,Olivier Lozach,Émilie Durieu,Tsutomu Fukuda,Fumito Ishibashi,Laurent Meijer,Masatomo Iwao	57
18	Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors 2012 ·European Journal of Medicinal Chemistry ·(unknown),Pascal Marchand,(unknown),Marie‐Renée Nourrisson,Muriel Duflos,Olivier Lozach,Nadège Loaëc,Laurent Meijer,Thierry Besson	50
19	Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases 2012 ·European Journal of Medicinal Chemistry ·(unknown),Pascal Marchand,(unknown),Marie‐Renée Nourrisson,Muriel Duflos,Nadège Loaëc,Laurent Meijer,Thierry Besson	45
20	CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells 2010 ·Genes & Cancer ·Karima Bettayeb,(unknown),(unknown),Nadège Loaëc,Alison J. Hole,Sonja Baumli,Jane Endicott,Sétha Douc‐Rasy,Jean Bénard,Nassima Oumata,Hervé Galons,Laurent Meijer	68

About Nadège Loaëc

Nadège Loaëc is a scholar working on Toxicology, Organic Chemistry and Genetics, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Quinazolinone synthesis and applications (8 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers) and Synthesis and biological activity (6 papers). The work is most often cited by research in Organic Chemistry (391 citations), Toxicology (34 citations) and Molecular Biology (534 citations). Nadège Loaëc has collaborated with scholars based in France, Germany and United Kingdom. Frequent co-authors include Laurent Meijer, Thierry Besson, Olivier Lozach, Pascal Marchand, Marie‐Renée Nourrisson, Conrad Kunick, Lutz Preu, Hervé Galons, Nassima Oumata and Stefan Knapp. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact